Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios I Papathanasiou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|December 7, 2010
The antiplatelet and antithrombotic actions of statinsJohn V Mitsios, Athanasios I Papathanasiou, John A Goudevenos, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 18, 2006
The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery diseaseEvangelia S Lourida, Athanasios I Papathanasiou, John A Goudevenos, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 13, 2008
Acute and long-term antiplatelet therapyAthanasios I Papathanasiou, John A Goudevenos, Dimitri P Mikhailidis, et al.
Platelets|July 14, 2005
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Moses Elisaf, et al.
Atherosclerosis|December 5, 2006
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentAthanasios I Papathanasiou, Evangelia S Lourida, Loukas D Tsironis, et al.
Circulation|March 17, 2004
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Foteini I Rodis, et al.
Angiology|May 13, 2005
Rare association of diffused coronary ectasia and anomalous origin of left circumflex coronary artery in a man with heterozygous familial hypercholesterolemia: a case reportAthanasios I Papathanasiou, Christos S Katsouras, Ioannis A Goudevenos, et al.
Arthritis Research & Therapy|March 1, 2007
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2Evangelia S Lourida, Athanasios N Georgiadis, Eleni C Papavasiliou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|December 7, 2010
The antiplatelet and antithrombotic actions of statinsJohn V Mitsios, Athanasios I Papathanasiou, John A Goudevenos, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|July 18, 2006
The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery diseaseEvangelia S Lourida, Athanasios I Papathanasiou, John A Goudevenos, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 13, 2008
Acute and long-term antiplatelet therapyAthanasios I Papathanasiou, John A Goudevenos, Dimitri P Mikhailidis, et al.
Platelets|July 14, 2005
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Moses Elisaf, et al.
Atherosclerosis|December 5, 2006
Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatmentAthanasios I Papathanasiou, Evangelia S Lourida, Loukas D Tsironis, et al.
Circulation|March 17, 2004
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromesJohn V Mitsios, Athanasios I Papathanasiou, Foteini I Rodis, et al.
Angiology|May 13, 2005
Rare association of diffused coronary ectasia and anomalous origin of left circumflex coronary artery in a man with heterozygous familial hypercholesterolemia: a case reportAthanasios I Papathanasiou, Christos S Katsouras, Ioannis A Goudevenos, et al.
Arthritis Research & Therapy|March 1, 2007
Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2Evangelia S Lourida, Athanasios N Georgiadis, Eleni C Papavasiliou, et al.
Pageof 1